Nemes Rush Group’s Pfizer PFE Stock Holding History

Nemes Rush Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$292K	Buy	12,129 +3,080	+34%	+$80.6K	0.02%	187
2026 Q1	$254K	Sell	9,049 -635	-7%	-$16.9K	0.02%	191
2025 Q4	$241K	Sell	9,684 -3,963	-29%	-$99.9K	0.02%	195
2025 Q3	$348K	Sell	13,647 -14,897	-52%	-$368K	0.03%	150
2025 Q2	$692K	Sell	28,544 -86,066	-75%	-$2.01M	0.08%	109
2025 Q1	$2.9M	Sell	114,610 -12,251	-10%	-$321K	0.37%	56
2024 Q4	$3.37M	Buy	126,861 +10,189	+9%	+$276K	0.42%	53
2024 Q3	$3.24M	Sell	116,672 -24,358	-17%	-$711K	0.47%	48
2024 Q2	$3.95M	Buy	141,030 +23,281	+20%	+$641K	0.54%	45
2024 Q1	$3.27M	Buy	117,749 +47,622	+68%	+$1.32M	0.47%	48
2023 Q4	$2.02M	Sell	70,127 -3,455	-5%	-$104K	0.33%	58
2023 Q3	$2.44M	Buy	73,582 +2,918	+4%	+$103K	0.44%	53
2023 Q2	$2.59M	Buy	+70,664	New	+$2.75M	0.46%	54

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nemes Rush Group's PFE Position: Q2 2026 in Review

Nemes Rush Group increased its Pfizer (PFE) stake by 34% in Q2 2026, buying an estimated $80.6K and bringing the position to 12,129 shares worth $292K. The position accounts for 0.02% of the portfolio, ranked #187.

Nemes Rush Group first reported a position in PFE in Q2 2023 and has held it in 13 quarters since. The position peaked at $3.95M in Q2 2024. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Nemes Rush Group held 12,129 shares of Pfizer worth $292K as of Q2 2026.
Nemes Rush Group bought 3,080 Pfizer shares in Q2 2026, an estimated $80.6K.
Pfizer made up 0.02% of Nemes Rush Group's portfolio in Q2 2026, its #187 holding.
Nemes Rush Group first reported a position in Pfizer in Q2 2023 and has held it in 13 quarters since.
Nemes Rush Group's Pfizer position peaked at $3.95M in Q2 2024.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.